MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejvs.2025.12.048

Медицинская библиотека · European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery · 2025

First in Human Aortic Aneurysm Sac Filling with AneuFix Injectable Polymer during Endovascular Aneurysm Repair.

Smorenburg Stefan P M, Lely Rutger J, Jongkind Vincent, Groeneveld Menno E, de Vries Alexander C, Brom Henri L F, Jacobs Michael J, Hoksbergen Arjan W J

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Type II endoleak (T2EL) after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA) can lead to aneurysm growth and rupture. Filling the aneurysm sac around the stent graft during EVAR may prevent T2EL. This study evaluated the feasibility and safety of a novel injectable polymer (AneuFix, TripleMed, Geleen, the Netherlands), for sac filling during EVAR in patients at high risk of T2EL.

METHODS

This first in human, single arm, single centre feasibility trial (ClinicalTrials.gov identifier: NCT04307992) included five patients with infrarenal AAA at high risk of T2EL. During EVAR, a filling sheath was positioned within the aneurysm, and the sac was filled with injectable polymer around the stent graft. Primary outcomes were technical success and safety (serious adverse events (SAEs) related to the procedure or device). Secondary outcomes included AAA diameter, volume, T2EL presence at six and 12 months, procedural metrics, re-intervention, rupture, and death. Post-treatment evaluations were performed by a Data Safety and Monitoring Board after treatment of the second, fourth, and fifth patients.

RESULTS

Four men and one woman (median age 68 years; range 63 - 82 years) were treated. Technical success was 100% (five of five), with complete aortic lumen filling. No device related SAEs occurred. One procedure related SAE (1.5 L blood loss via access sheath) resolved without clinical sequelae. Median polymer volume was 50 mL (range 22 - 70 mL) and injection time was seven minutes (range 4 - 13 minutes). The median AAA diameter decreased from 62 mm after procedure to 60 mm and 56 mm at six and 12 months, respectively. AAA volume decreased from 167 mL to 148 mL and 127 mL. No T2ELs or re-interventions occurred during follow up when assessable.

CONCLUSION

In this first in human series, injectable polymer sac filling during EVAR appeared technically feasible and safe, with all patients showing sac shrinkage at 12 months. A multicentre feasibility and safety trial is in progress.

Для цитирования: Smorenburg Stefan P M, Lely Rutger J, Jongkind Vincent, Groeneveld Menno E, de Vries Alexander C, Brom Henri L F, Jacobs Michael J, Hoksbergen Arjan W J. First in Human Aortic Aneurysm Sac Filling with AneuFix Injectable Polymer during Endovascular Aneurysm Repair.. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 2025. DOI: 10.1016/j.ejvs.2025.12.048.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.